Correlation Between Eliem Therapeutics and Quoin Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Eliem Therapeutics and Quoin Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eliem Therapeutics and Quoin Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eliem Therapeutics and Quoin Pharmaceuticals Ltd, you can compare the effects of market volatilities on Eliem Therapeutics and Quoin Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eliem Therapeutics with a short position of Quoin Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eliem Therapeutics and Quoin Pharmaceuticals.
Diversification Opportunities for Eliem Therapeutics and Quoin Pharmaceuticals
-0.09 | Correlation Coefficient |
Good diversification
The 3 months correlation between Eliem and Quoin is -0.09. Overlapping area represents the amount of risk that can be diversified away by holding Eliem Therapeutics and Quoin Pharmaceuticals Ltd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Quoin Pharmaceuticals and Eliem Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eliem Therapeutics are associated (or correlated) with Quoin Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Quoin Pharmaceuticals has no effect on the direction of Eliem Therapeutics i.e., Eliem Therapeutics and Quoin Pharmaceuticals go up and down completely randomly.
Pair Corralation between Eliem Therapeutics and Quoin Pharmaceuticals
Given the investment horizon of 90 days Eliem Therapeutics is expected to under-perform the Quoin Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Eliem Therapeutics is 2.77 times less risky than Quoin Pharmaceuticals. The stock trades about -0.28 of its potential returns per unit of risk. The Quoin Pharmaceuticals Ltd is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest 49.00 in Quoin Pharmaceuticals Ltd on August 30, 2024 and sell it today you would earn a total of 11.00 from holding Quoin Pharmaceuticals Ltd or generate 22.45% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Eliem Therapeutics vs. Quoin Pharmaceuticals Ltd
Performance |
| Timeline |
| Eliem Therapeutics |
| Quoin Pharmaceuticals |
Eliem Therapeutics and Quoin Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eliem Therapeutics and Quoin Pharmaceuticals
The main advantage of trading using opposite Eliem Therapeutics and Quoin Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eliem Therapeutics position performs unexpectedly, Quoin Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Quoin Pharmaceuticals will offset losses from the drop in Quoin Pharmaceuticals' long position.| Eliem Therapeutics vs. Pmv Pharmaceuticals | Eliem Therapeutics vs. MediciNova | Eliem Therapeutics vs. Pharvaris BV | Eliem Therapeutics vs. PepGen |
| Quoin Pharmaceuticals vs. Ikena Oncology | Quoin Pharmaceuticals vs. Eliem Therapeutics | Quoin Pharmaceuticals vs. HCW Biologics | Quoin Pharmaceuticals vs. RenovoRx |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |